Platinum-sensitive Ovarian Cancer Clinical Trials

15 clinical trials for Platinum-sensitive Ovarian Cancer across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer — RECRUITING · PHASE3
• Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) — RECRUITING · PHASE1
• Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy — RECRUITING · PHASE3
• A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies — RECRUITING · PHASE2
• Combination Therapy of AK112 With Chemotherapy and/or Olaparib in Platinum-sensitive Ovarian Cancer — RECRUITING · PHASE2
• Iparomlimab/Tuvonralimab + Standard Chemotherapy and Olaparib in Platinum-Sensitive Recurrent Ovarian Cancer — NOT_YET_RECRUITING · PHASE2
• Statin Therapy to Reduce Progression in Women With Platinum Sensitive Ovarian Cancer — COMPLETED · PHASE1
• RESCUE Study (REcurrent Ovarian Cancer Secondary Cytoreduction Using Chemotherapy rEsponse) — NOT_YET_RECRUITING · PHASE2
• OSE2101 Alone or in Combination With Pembrolizumab vs BSC in Patient With Platinum-sensitive Recurrent OC — ACTIVE_NOT_RECRUITING · PHASE2
• Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors — COMPLETED · PHASE1
• Study of Upifitamab Rilsodotin in Combination With Carboplatin in Participants With High-grade Serous Ovarian Cancer — TERMINATED · PHASE1
• A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer — COMPLETED · PHASE3
• Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer — TERMINATED · PHASE2
• Variance of HRD From Paired Ovarian Cancer — OTHER
• Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-Treatment — TERMINATED · PHASE4

Refine this search